Mason Capital complains about Grifols' transparency to Spanish regulator

Editorial & Advertiser disclosure

Global Banking and Finance Review is an online platform offering news, analysis, and opinion on the latest trends, developments, and innovations in the banking and finance industry worldwide. The platform covers a diverse range of topics, including banking, insurance, investment, wealth management, fintech, and regulatory issues. The website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website.

Finance

Posted By Global Banking and Finance

Posted on January 14, 2025

Mason Capital complains about Grifols' transparency to Spanish regulator

MADRID (Reuters) - U.S.-based investment fund Mason Capital said on Monday it had sent a letter to Spain's stock market regulator CNMV demanding more transparency from the embattled pharmaceutical company Grifols.

The activist fund said in a statement it had identified potential conflicts of interest linked to related party transactions by current board members, failure of internal controls and a "rumoured clause" in a recent bond issuance that benefits Canadian fund Brookfield at shareholders' expense.

"We urge the CNMV to consider the benefits to all Grifols shareholders from improved disclosure," Mason Capital said.

The CNMV declined to comment about the letter.

Grifols shares were down around 3% in late afternoon trading following the statement by Mason Capital, which owns a stake of about 2.5% in Grifols.

In early January 2024, Grifols lost about a third of its value in a few hours after short seller fund Gotham City Research questioned its accounting and the size of its debt. The share price has not fully recovered.

Barcelona-based Grifols denied any wrongdoing and sued Gotham City. It also made a series of governance changes, appointing a new CEO following the incident, and revised the value of its debt.

In November, Brookfield dropped a plan to take over the human-plasma drug developer, together with the founding Grifols family, that valued it at 6.45 billion euros. The deal fell through due to a disagreement over the valuation.

(Reporting by Inti Landauro, editing by Andrei Khalip)

Recommended for you